Details.
Clinical gastrointestinal metagenomic testing using shotgun metagenomic next-generation sequencing on a single faecal sample. The test uncovers 175 targets in one report, including 100 gastrointestinal pathogens, 15 virulence factors and 60 antimicrobial resistance genes, and provides gut microbiome diversity and richness scores. It is particularly suited to patients with non-specific chronic gastrointestinal symptoms, relapses in inflammatory bowel disease, and immunosuppressed patients at risk of severe gastrointestinal infections or sepsis. Every report is reviewed by an expert pathologist who provides evidence-based and referenced clinical recommendations.